If PLP is normal or low, investigate other causes including B12 deficiency, thiamine deficiency, or diabetes-related neuropathy
Disability-analysis of State Reports, reviewed by the Committee on the Rights of the Child (CRC) in its Pre-Sessional Working Group, 55 th Session
The most significant regulatory development is the CMS Interoperability and Prior Authorization Final Rule (CMS-0057-F) , which took effect January 1, 2026
Conclusions GLP-1 analogues are an effective treatment for weight loss, and the addition of bupropion/naltrexone is associated with greater weight loss including in patients who are initially non-responsive to GLP-1 analogues
Ideal persons to receive these injections are people who have undergone plastic surgery and are unable to absorb vitamin B12 in the body
Victoza (liraglutide) EPAR - product information